ReviewFrontiers in immunology2020

How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?

Mingming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.